5-Fluorouracil (5-FU) is a chemotherapy medication primarily used to treat various types of cancer, including colorectal, breast, stomach, and pancreatic cancers. It belongs to the class of antimetabolites and works by interfering with the synthesis of DNA and RNA in rapidly dividing cancer cells.
5-FU is widely used to treat solid tumors, especially colorectal cancer. It is also effective against breast, stomach, esophageal, and pancreatic cancers. In dermatology, topical 5-FU is used to treat actinic keratosis and superficial basal cell carcinoma.
| Brand Name | 5-Fluril |
|---|---|
| Type | IV Injection or Infusion |
| Weight | 25 mg/ml |
| Generic | 5-Fluorouracil [5-FU] |
| Manufacturer | Techno Drugs Ltd. |
| Available in | English বাংলা |
5-FU is a pyrimidine analog that inhibits thymidylate synthase, an enzyme required for DNA synthesis. It is converted into active metabolites that disrupt both RNA and DNA synthesis, leading to the inhibition of cell division and eventual cell death, particularly in rapidly dividing cancer cells.
The effects of 5-FU vary depending on the type of cancer being treated, the method of administration, and individual patient factors. It may take several weeks to observe a clinical response. However, biochemical changes in cancer cells can begin shortly after treatment initiation.
5-FU has poor oral bioavailability due to extensive first-pass metabolism, which is why it is primarily administered intravenously or topically. When given intravenously, it is rapidly absorbed into the bloodstream.
5-FU is primarily metabolized in the liver by the enzyme dihydropyrimidine dehydrogenase (DPD). It is excreted mainly via the kidneys as metabolites, with a small portion eliminated through the lungs as carbon dioxide.
Intravenous Dosage (Cancer Treatment):
5-FU can be administered as an intravenous bolus, continuous intravenous infusion, or topically. Intravenous administration is the most common method in cancer treatment, either as a single agent or part of a combination regimen. Topical administration is used for skin conditions like actinic keratosis.
Common side effects include nausea, vomiting, diarrhea, mucositis, myelosuppression (low blood cell counts), and hand-foot syndrome (palmar-plantar erythrodysesthesia). More severe side effects may include cardiac toxicity, neurotoxicity, and hepatotoxicity.
Overdosing on 5-FU can lead to severe gastrointestinal toxicity, bone marrow suppression, neurotoxicity, and death. Symptoms of overdose include severe nausea, vomiting, diarrhea, bleeding, and infection due to immunosuppression. Immediate medical intervention is required.
Patients with a deficiency of the enzyme dihydropyrimidine dehydrogenase (DPD) are at increased risk of severe toxicity from 5-FU. Pre-screening for DPD deficiency may be recommended. Caution is also advised in patients with pre-existing cardiac disease, liver dysfunction, or poor nutritional status.
5-FU interacts with other chemotherapy agents, anticoagulants, and medications that affect liver function. Combining 5-FU with leucovorin enhances its effectiveness by stabilizing the binding of 5-FU to thymidylate synthase. It may also interact with radiation therapy, increasing radiation sensitivity in cancer cells.
Patients with a history of cardiac disease may experience increased cardiotoxicity with 5-FU. Additionally, those with liver or kidney dysfunction may require dose adjustments due to altered metabolism and clearance of the drug.
5-FU can interact with anticoagulants such as warfarin, increasing the risk of bleeding. It may also interact with other chemotherapy agents, immunosuppressants, and radiation therapy, enhancing both therapeutic and toxic effects.
There are no major known food interactions with 5-FU, but patients are generally advised to maintain good nutrition to support overall health during chemotherapy. Alcohol may exacerbate side effects like nausea and liver toxicity.
5-FU is classified as Category D for pregnancy, meaning there is positive evidence of risk to the fetus. It should not be used during pregnancy unless absolutely necessary, and effective contraception should be used during treatment.
5-FU is contraindicated during lactation as it can be excreted into breast milk and may harm the nursing infant. Breastfeeding should be discontinued during treatment.
Acute overdose of 5-FU can result in severe gastrointestinal toxicity, myelosuppression, and even death. Immediate management may include supportive care, hydration, anti-nausea medications, and blood transfusions if necessary. In severe cases, the use of the antidote uridine triacetate can reduce the toxicity of 5-FU.
5-FU is contraindicated in patients with known hypersensitivity to the drug, DPD deficiency, and in pregnant or breastfeeding women. It should also be avoided in patients with severe bone marrow suppression.
5-FU should be administered by a healthcare professional in a hospital or clinic setting when used for cancer treatment. Topical forms should be applied according to the prescription, avoiding contact with the eyes and mucous membranes.
5-FU should be stored at controlled room temperature (20-25°C). Topical forms should be protected from light and moisture. Intravenous solutions should be used immediately after preparation and any unused portion discarded.
5-FU has a moderate volume of distribution, allowing it to diffuse into various tissues, including tumors. It is widely distributed in the body but has limited penetration into the central nervous system.
The half-life of 5-FU is approximately 10-20 minutes when given as a bolus injection due to rapid metabolism by the liver. Continuous infusion leads to a longer effective half-life and more sustained plasma levels.
5-FU is primarily cleared by the liver through metabolism by DPD. A small fraction of the drug is excreted unchanged in the urine. The clearance rate may be significantly reduced in patients with DPD deficiency or liver dysfunction.
See in details version 5-Fluril IV Injection or Infusion 25 mg/ml also 5-Fluril IV Injection or Infusion 25 mg/ml in bangla
5-Fluorouracil (5-FU) is a chemotherapy drug used to treat various types of cancer by interfering with the growth of cancer cells.
It is commonly used to treat:
5-FU inhibits DNA and RNA synthesis, preventing cancer cells from dividing and growing.
It can be given as:
No, 5-FU is usually given as an IV infusion or a topical cream, not as an oral tablet.
It varies depending on the cancer type and treatment plan, typically lasting from a few weeks to several months.
Side effects may include:
It may cause hair thinning, but complete hair loss is uncommon.
Yes, nausea is a common side effect, but anti-nausea medications can help.
It is rapidly metabolized, but its effects on cancer cells can last for days to weeks.
Yes, but a balanced, nutritious diet is recommended to manage side effects.
Yes, it may temporarily or permanently affect fertility in both men and women.
Alcohol can worsen side effects, so it is best to avoid it during treatment.
Yes, it is often combined with drugs like leucovorin, oxaliplatin, or irinotecan for better effectiveness.
It can lower white blood cell counts, making patients more prone to infections.
Live vaccines should be avoided, but inactivated vaccines may be safe under doctor supervision.
Yes, liver function should be monitored during treatment.
Patients should:
It is rarely used in children and only under strict medical supervision.
Yes, topical 5-FU is used for actinic keratosis and basal cell carcinoma.
Yes, mouth sores (stomatitis) are a common side effect.
No, it can cause severe birth defects and is not safe during pregnancy.
No, 5-FU can pass into breast milk and harm the baby.
Rarely, it can cause chest pain or heart rhythm issues.
Apply a thin layer to the affected skin, as directed by a doctor.
Yes, it may cause eye redness and irritation, especially in topical form.
Yes, it may interact with blood thinners, phenytoin, and other chemotherapy drugs.
Some supplements may interfere with treatment. Always consult your doctor first.
No, it is usually given in cycles over weeks or months.
Yes, fatigue is a common side effect during and after treatment.
Contact your doctor immediately for guidance.
Yes, due to nausea, vomiting, and reduced appetite.
It is not commonly used for lung cancer but may be included in some regimens.
Keep it in a cool, dry place away from direct sunlight.
Yes, kidney function should be monitored during treatment.
Light exercise is okay, but avoid strenuous activity.
Yes, chemotherapy drugs can impact mood and mental health.
Yes, dizziness and weakness are possible side effects.
Yes, but consult your doctor and carry medical records.
It can, especially in diabetic patients.
If you feel weak or dizzy, avoid driving.
Yes, skin discoloration may occur as a side effect.
No, always follow the prescribed treatment plan.
Dr. Mahbub Ara Chowdhury Shiuly
Gynecology, Infertility Specialist & Surgeon
Gynecologist in Rajshahi